Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou, China.
Key Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Stem Cell Rev Rep. 2024 Jan;20(1):301-312. doi: 10.1007/s12015-023-10631-0. Epub 2023 Oct 13.
Aplastic anaemia (AA) is a haematopoietic disorder caused by immune-mediated attack on haematopoietic stem cells (HSCs). Stem cell transplantation and immunosuppressive therapy remain the major treatment choice for AA patients but have limited benefits and undesired side effects. The aim of our study was to clarify the protective role of immunity of chronic intermittent hypobaric hypoxia (CIHH) and the underlying mechanism in AA. Our integrative analysis demonstrated that CIHH pre-treatment significantly improved haematopoiesis and survival in an AA rat model. We further confirmed that CIHH pre-treatment was closely associated with the Th1/Th2 balance and a large number of negative regulatory haematopoietic factors, such as TNF-α and IFN-γ, produced by hyperactive Th1 lymphocytes released in AA rats, which induced the death program in a large number of CD34 HSCs by activating the Fas/FasL apoptosis pathway, while CIHH pre-treatment effectively downregulated the expression of TNF-α and IFN-γ, resulting in a reduction in Fas antigen expression in CD34 HSCs. In summary, this study provides evidence that CIHH has good protective effect against AA by modulating immune balance in Th1/Th2 cells and may provide a new therapeutic strategy.
再生障碍性贫血(AA)是一种由免疫介导的造血干细胞(HSCs)攻击引起的造血系统疾病。干细胞移植和免疫抑制治疗仍然是 AA 患者的主要治疗选择,但疗效有限,且存在不良副作用。我们的研究旨在阐明慢性间歇性低氧(CIHH)对 AA 的免疫保护作用及其潜在机制。综合分析表明,CIHH 预处理可显著改善 AA 大鼠模型的造血功能和存活率。我们进一步证实,CIHH 预处理与 Th1/Th2 平衡以及大量由 AA 大鼠中过度活跃的 Th1 淋巴细胞释放的负性调节造血因子密切相关,这些因子通过激活 Fas/FasL 凋亡途径诱导大量 CD34 HSCs 进入死亡程序,而 CIHH 预处理可有效下调 TNF-α 和 IFN-γ 的表达,从而降低 CD34 HSCs 中 Fas 抗原的表达。综上所述,该研究表明 CIHH 通过调节 Th1/Th2 细胞免疫平衡对 AA 具有良好的保护作用,可能为治疗 AA 提供一种新的策略。